APA (7th ed.) Citation

Bahlis, N. J., Trudel, S., Quach, H., Popat, R., Lonial, S., Orlowski, R. Z., . . . Richardson, P. (2023). P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL. Wiley.

Chicago Style (17th ed.) Citation

Bahlis, Nizar J., et al. P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL. Wiley, 2023.

MLA (9th ed.) Citation

Bahlis, Nizar J., et al. P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL. Wiley, 2023.

Warning: These citations may not always be 100% accurate.